Trial intelligence / Profile preview

Bupivacaine vs meperidine in erector spinae plane block for lumbar spine surgery

IRCT20210415050983N5Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in lumbar disc disease comparing Bupivacaine ESP block with Meperidine ESP block (2 arms). Primary endpoints: Intraoperative hypnotic consumption and Postoperative pain. Started Sep 2023; status: completed.

02

Drugs

bupivacainepethidine
03

Conditions

lumbar disc disease

Beyond the preview

Go deeper on IRCT20210415050983N5.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20210415050983N5.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call